A Risk-Benefit Assessment of Drugs Used in the Eradication of Helicobacter pylori Infection
- 1 July 1996
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 15 (1) , 30-52
- https://doi.org/10.2165/00002018-199615010-00003
Abstract
Helicobacter pylori is the cause of chronic active gastritis and predisposes to peptic ulcer disease (PUD). Furthermore, H. pyloriis linked to the pathogenesis of gastric lymphoma and gastric...Keywords
This publication has 96 references indexed in Scilit:
- LansoprazoleDrugs, 1994
- Over-the-Counter Histamine H2-Receptor AntagonistsDrugs, 1994
- Colloidal bismuth subcitrate and omeprazole inhibit alcohol dehydrogenase mediated acetaldehyde production by Helicobacter pyloriLife Sciences, 1992
- LansoprazoleDrugs, 1992
- ClarithromycinDrugs, 1992
- Effect of omeprazole on duodenal ulcer-associated antral gastritis andHelicobacter pyloriDigestive Diseases and Sciences, 1991
- RanitidineDrugs, 1989
- A Randomized Study of Maintenance Therapy with Ranitidine to Prevent the Recurrence of Duodenal UlcerNew England Journal of Medicine, 1989
- Colloidal Bismuth SubcitrateDrugs, 1988
- Tri-potassium Di-citrato BismuthateDrugs, 1976